Carlo leads global medical and scientific initiatives aimed at advancing evidence-based colorectal cancer screening. Drawing on his experience across companies like Roche, Agilent, Abbott, and Exact Sciences, he focuses on oncology diagnostics, evidence generation, and market development to turn scientific innovation into clinical practice and improve early detection.

Mark brings broad life sciences leadership across global, regional, and affiliate medical affairs roles. With a background spanning R&D, commercial, and MSL excellence, he focuses on building high-performing field medical teams, driving cross-functional collaboration, and leveraging data and technology to elevate external engagement.

Steve leads ABHI’s regulatory policy for IVDs and digital health, representing members with the MHRA and IMDRF to drive global regulatory convergence. He brings over two decades of experience from the MHRA, where he also chaired the European Commission’s IVD working group during the development of the IVDR.

With 15+ years of experience, Egbert is a regulatory affairs and quality assurance professional specializing in medical devices, EU MDR (2017/745), ISO 13485, MDSAP, global market access, and PRRC responsibilities. He has a proven track record of leading international RA teams, securing certifications, managing quality audits, and modernizing regulatory processes with AI.

Christy has 25+ years of experience across the pharmaceutical and medical device industries in sponsor and CRO settings. For nearly five years, she has partnered with Veeva and leads a team of clinical data managers and database programmers supporting multiple BD business units. Christy delivers end-to-end data management—from study start-up through database lock—by championing interoperable workflows (EDC, eCOA, CDB) that reduce burden, accelerate insights, and strengthen compliance.

With over 25 years at bioMérieux—including a decade in regulatory affairs—Marie-Pierre leads the lifecycle management and regulatory policy and intelligence teams. Under her leadership, bioMérieux implemented Veeva Vault RIM in May 2025, fundamentally transforming operations by securing regulatory traceability, boosting efficiency, and scaling across corporate teams and most global subsidiaries.

Alejandra is a clinical technology leader specializing in modernizing clinical trial data flows. She leverages AI, workflow automation, and real-time data integration to build scalable platforms that streamline operations and accelerate the delivery of life-changing medicines.

With 16 years of NHS experience as a cardiac clinical physiologist, Richard joined BSI in 2018, where he is now head of clinical compliance. He is also involved in EU Medical Device Coordination Group (MDCG) working groups.

Alex is head of notified body IVD at BSI. As a bioprocess engineer, he brings over 12 years of notified body leadership from DEKRA and KEMA, complemented by extensive QA/RA industry experience and four years as a regulatory consultant.

Handan governs global quality processes and digital systems, including the Veeva Quality Platform, across the full product lifecycle. She joined Coloplast in 2014 and has held key leadership positions at both HQ and manufacturing sites, specializing in scaling quality capabilities that simplify compliance.

Sandra leads initiatives in regulatory intelligence, digital transformation, and CMC strategy at Cytiva. She brings over 25 years of experience in QA/RA and specializes in global regulatory frameworks and digital enablement like Veeva RIM to accelerate submissions and drive compliant, data-driven ecosystems.

Blake leads strategic commercial initiatives across CRM transformation, data management, customer engagement, and field enablement EMEA. By aligning business strategy with technology, he focuses on balancing rapid value delivery with long-term capability building to drive measurable growth. Previously, Blake led commercial strategy and technology initiatives for medtech organizations at ZS.

Alongside his role at DNV Product Assurance, Alex serves as President of Team-NB, the European Association of Notified Bodies for medical devices. He brings over 13 years of notified body experience, building on his previous career in medical research and pediatric surgery.

With more than 13 years in the IVD industry, Tom now serves as IVDR/IVD International Manager at GMED and Secretary of the NBCG-Med executive committee. His background includes over 5 years of notified body experience, featuring multiple leadership roles.

Maxine leads a global MSL team across Europe, Latin America, APAC, and the Middle East, overseeing international medical affairs for neuromodulation technologies. A neuroscientist with over 60 peer-reviewed publications, she has collaborated with more than 100 physicians on pivotal clinical studies. Her current work focuses on using AI to optimize clinical workflows and redefine healthcare provider engagement.

Becki leads regulatory affairs initiatives for advertising and promotion at Medtronic. She also focuses on modernizing promotional review workflows and scaling digital solutions across highly regulated environments.

Rob leads the MHRA’s innovative devices team, driving the reform of the UK’s medical device regulations as deputy director. He draws on five years of regulatory policy experience at the office for life sciences and a background leading the national physical laboratory’s biometrology group.

Brian modernizes global operations at Novocure across clinical, safety, supply chain, quality, and regulatory. He specializes in platform-based strategies that reduce complexity, scale workflows, and align technology solutions with broader business goals.

A seasoned quality executive in the medtetch industry, Zoya drives global quality strategy, regulatory compliance, and operational excellence across complex device platforms. She specializes in building agile quality cultures that support rapid innovation, enabling the safe delivery of life-changing therapies to patients worldwide.

Jos leads the claims program at Philips, driving the enterprise deployment of Veeva PromoMats. Leveraging his medtech innovation background, he collaborates across commercial, regulatory, and IT functions to scale compliant, AI-enabled content and global localization.

A physician executive with over 15 years of global leadership in pharma and medical devices, Carla has driven clinical research and safety initiatives across three continents. She is a dedicated advocate for closing the women’s health gap and expanding equitable access to critical care.

Martijn brings 10 years of medtech experience leading medical affairs, safety, and clinical strategy across MRI, CT, and Diagnostic X-Ray portfolios. Previously, he led image-guided therapy innovations, launched Vygon’s homecare business, and served as head of operating rooms at the Netherlands central military hospital. He holds medical degrees alongside an executive MBA and advanced qualifications in business and healthcare management.

Joanna leads the clinical vision for next-generation diabetes technologies, bringing together science, clinical practice, and stakeholder insights. Leveraging her background as a practicing endocrinologist and former Joslin Diabetes Center leader, she builds cross-functional partnerships that advance innovative care models and improve patient lives.

Nia brings 26 years of leadership across product management and medical device risk management, driving product quality and safety throughout the medical technology lifecycle. She began her career spending seven years as a hospital physicist in London and holds a PhD in radiation physics.

Kolja Boese leads global medical strategy across the product lifecycle in medtech, overseeing clinical evidence, safety governance, and EU MDR oversight. A board-certified surgeon and University of Hamburg lecturer, he focuses on integrating pharmaceutical development, scalable data-driven evidence generation, and responsible AI.

With 15 years of quality and regulatory experience, Markus is an expert in data-driven post-market surveillance and European regulatory compliance. He chairs MedTech Europe’s PMS & vigilance working group, contributes to MDCG task forces, and is a recipient of the 2026 RAPS 50for50 regulatory trailblazer award.

With 20 years of medtech experience, John leads global clinical evidence generation at Teleflex. He specializes in international clinical programs and RWE for FDA/MDR approvals, combining scientific rigor with a strategic mindset to drive global market adoption.

With over 25 years of quality and regulatory experience, Koen manages medical device and CDMO plants, driving operational excellence through practical, compliant, and locally adaptable processes. As a bio-engineer, he bridges global standards with local site needs to empower high-performing, cross-functional teams.

Emiliano leads post-market surveillance strategy, vigilance, and IVDR regulatory intelligence at Tosoh Bioscience – Diagnostics EMEA. He also chairs MedTech Europe’s IVD PMS & vigilance working group, drawing on deep expertise in PMS, PSURs, EUDAMED readiness, and QMS integration to align regulators, notified bodies, and industry on practical EU compliance.